These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32337342)

  • 1. Neurologic outcomes in Friedreich ataxia: Study of a single-site cohort.
    Pandolfo M
    Neurol Genet; 2020 Jun; 6(3):e415. PubMed ID: 32337342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS): a 4-year cohort study.
    Reetz K; Dogan I; Hilgers RD; Giunti P; Parkinson MH; Mariotti C; Nanetti L; Durr A; Ewenczyk C; Boesch S; Nachbauer W; Klopstock T; Stendel C; Rodríguez de Rivera Garrido FJ; Rummey C; Schöls L; Hayer SN; Klockgether T; Giordano I; Didszun C; Rai M; Pandolfo M; Schulz JB;
    Lancet Neurol; 2021 May; 20(5):362-372. PubMed ID: 33770527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological and clinical characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS) cohort: a cross-sectional analysis of baseline data.
    Reetz K; Dogan I; Costa AS; Dafotakis M; Fedosov K; Giunti P; Parkinson MH; Sweeney MG; Mariotti C; Panzeri M; Nanetti L; Arpa J; Sanz-Gallego I; Durr A; Charles P; Boesch S; Nachbauer W; Klopstock T; Karin I; Depondt C; vom Hagen JM; Schöls L; Giordano IA; Klockgether T; Bürk K; Pandolfo M; Schulz JB
    Lancet Neurol; 2015 Feb; 14(2):174-82. PubMed ID: 25566998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS): a 2 year cohort study.
    Reetz K; Dogan I; Hilgers RD; Giunti P; Mariotti C; Durr A; Boesch S; Klopstock T; de Rivera FJR; Schöls L; Klockgether T; Bürk K; Rai M; Pandolfo M; Schulz JB;
    Lancet Neurol; 2016 Dec; 15(13):1346-1354. PubMed ID: 27839651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of loss of ambulation in Friedreich's ataxia.
    Rummey C; Farmer JM; Lynch DR
    EClinicalMedicine; 2020 Jan; 18():100213. PubMed ID: 31938785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of a Scale for the Assessment and Rating of Ataxia (SARA) in Friedreich's ataxia patients according to posturography is limited.
    Schwabova J; Maly T; Laczo J; Zumrova A; Komarek V; Musova Z; Zahalka F
    J Neurol Sci; 2014 Jun; 341(1-2):64-7. PubMed ID: 24768059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Friedreich and dominant ataxias: quantitative differences in cerebellar dysfunction measurements.
    Tanguy Melac A; Mariotti C; Filipovic Pierucci A; Giunti P; Arpa J; Boesch S; Klopstock T; Müller Vom Hagen J; Klockgether T; Bürk K; Schulz JB; Reetz K; Pandolfo M; Durr A; Tezenas du Montcel S;
    J Neurol Neurosurg Psychiatry; 2018 Jun; 89(6):559-565. PubMed ID: 29279305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural History of Friedreich Ataxia: Heterogeneity of Neurologic Progression and Consequences for Clinical Trial Design.
    Rummey C; Corben LA; Delatycki M; Wilmot G; Subramony SH; Corti M; Bushara K; Duquette A; Gomez C; Hoyle JC; Roxburgh R; Seeberger L; Yoon G; Mathews K; Zesiewicz T; Perlman S; Lynch DR
    Neurology; 2022 Oct; 99(14):e1499-e1510. PubMed ID: 35817567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developing an objective evaluating system to quantify the degree of upper limb movement impairment in patients with severe Friedreich's ataxia.
    Arcuria G; Marcotulli C; Amuso R; Dattilo G; Galasso C; Pierelli F; Casali C
    Neurol Sci; 2020 Jun; 41(6):1577-1587. PubMed ID: 31993871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of rehabilitation intervention in persons with Friedreich ataxia.
    Paparella G; Stragà C; Vavla M; Pesenti N; Merotto V; Martorel GA; Zalunardo S; Armellin M; Comiotto J; Martinuzzi A
    Front Neurol; 2023; 14():1270296. PubMed ID: 38020600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonataxia symptoms in Friedreich Ataxia: Report from the Registry of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS).
    Reetz K; Dogan I; Hohenfeld C; Didszun C; Giunti P; Mariotti C; Durr A; Boesch S; Klopstock T; Rodríguez de Rivera Garrido FJ; Schöls L; Giordano I; Bürk K; Pandolfo M; Schulz JB;
    Neurology; 2018 Sep; 91(10):e917-e930. PubMed ID: 30097477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robotic and clinical evaluation of upper limb motor performance in patients with Friedreich's Ataxia: an observational study.
    Germanotta M; Vasco G; Petrarca M; Rossi S; Carniel S; Bertini E; Cappa P; Castelli E
    J Neuroeng Rehabil; 2015 Apr; 12():41. PubMed ID: 25900021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring progression in Friedreich ataxia (FRDA): the use of clinical scales.
    Bürk K; Schulz SR; Schulz JB
    J Neurochem; 2013 Aug; 126 Suppl 1():118-24. PubMed ID: 23859347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of the disease course in Friedreich ataxia.
    Hohenfeld C; Terstiege U; Dogan I; Giunti P; Parkinson MH; Mariotti C; Nanetti L; Fichera M; Durr A; Ewenczyk C; Boesch S; Nachbauer W; Klopstock T; Stendel C; Rodríguez de Rivera Garrido FJ; Schöls L; Hayer SN; Klockgether T; Giordano I; Didszun C; Rai M; Pandolfo M; Rauhut H; Schulz JB; Reetz K
    Sci Rep; 2022 Nov; 12(1):19173. PubMed ID: 36357508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinant of the cerebellar cognitive affective syndrome in Friedreich's ataxia.
    Destrebecq V; Comet C; Deveylder F; Alaerts N; Naeije G
    J Neurol; 2023 Jun; 270(6):2969-2974. PubMed ID: 36790547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal changes of SARA scale in Friedreich ataxia: Strong influence of baseline score and age at onset.
    Porcu L; Fichera M; Nanetti L; Rulli E; Giunti P; Parkinson MH; Durr A; Ewenczyk C; Boesch S; Nachbauer W; Indelicato E; Klopstock T; Stendel C; Rodríguez de Rivera FJ; Schöls L; Fleszar Z; Giordano I; Didszun C; Castaldo A; Rai M; Klockgether T; Pandolfo M; Schulz JB; Reetz K; Mariotti C;
    Ann Clin Transl Neurol; 2023 Nov; 10(11):2000-2012. PubMed ID: 37641437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of three clinical rating scales in Friedreich ataxia (FRDA).
    Bürk K; Mälzig U; Wolf S; Heck S; Dimitriadis K; Schmitz-Hübsch T; Hering S; Lindig TM; Haug V; Timmann D; Degen I; Kruse B; Dörr JM; Ratzka S; Ivo A; Schöls L; Boesch S; Klockgether T; Klopstock T; Schulz JB
    Mov Disord; 2009 Sep; 24(12):1779-84. PubMed ID: 19562766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corneal confocal microscopy: Neurologic disease biomarker in Friedreich ataxia.
    Pagovich OE; Vo ML; Zhao ZZ; Petropoulos IN; Yuan M; Lertsuwanroj B; Ciralsky J; Lai E; Kiss S; D'Amico DJ; Mezey JG; Malik RA; Crystal RG
    Ann Neurol; 2018 Dec; 84(6):893-904. PubMed ID: 30294800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determining the Validity of Conducting Rating Scales in Friedreich Ataxia through Video.
    Tai G; Corben LA; Woodcock IR; Yiu EM; Delatycki MB
    Mov Disord Clin Pract; 2021 Jul; 8(5):688-693. PubMed ID: 34307740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiological, clinical, paraclinical and molecular study of a cohort of 102 patients affected with autosomal recessive progressive cerebellar ataxia from Alsace, Eastern France: implications for clinical management.
    Anheim M; Fleury M; Monga B; Laugel V; Chaigne D; Rodier G; Ginglinger E; Boulay C; Courtois S; Drouot N; Fritsch M; Delaunoy JP; Stoppa-Lyonnet D; Tranchant C; Koenig M
    Neurogenetics; 2010 Feb; 11(1):1-12. PubMed ID: 19440741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.